Ioannou M., Papamichali R., Samara M., Paraskeva E., Papacharalambous C., Baxevanidou K., Koukoulis G. (2016)
Purpose: V600E is the most common activating BRAF mutation in colorectal carcinomas (CRCs). It is a crucial biomarker for patient selection and response to targeted therapy with BRAF V600E inhibitors. Previous studies using ...